Medicare Coverage of HCT Recommended for Older Adults With Myelodysplastic Syndrome Medicare Coverage of HCT Recommended for Older Adults With Myelodysplastic Syndrome

A study of hematopoietic stem cell transplantation (HCT) for adults with myelodysplastic syndrome (MDS) showed that patients 65 and older had comparable outcomes to those ages 55 to 64, leading the authors to recommend that the US Centers for Medicare and Medicaid Services cover HCT.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news